Drag

Sakar Healthcare Limited

Healthcare SAKAR

391.10INR
3.30 ( 0.85%)

Last update at 2026-01-30 15:43:07

Day Range

376.10394.95
LowHigh

52 Week Range

210.10 444.30
LowHigh

Fundamentals

  • Previous Close 387.80
  • Market Cap 8567.05M
  • Volume7,877
  • P/E Ratio 43.85
  • EBITDA 515.45M
  • Revenue TTM 2044.78M
  • Revenue Per Share TTM 92.68
  • Gross Profit TTM 1076.64M
  • Diluted EPS TTM 8.90

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax 215.27M 159.00M 168.76M 189.32M 132.33M
Net income 175.02M 116.71M 127.59M 152.43M 106.83M
Total Revenue 1775.85M 1541.67M 1333.59M 1282.27M 947.39M
Gross Profit 427.91M 699.59M 598.12M 534.12M 432.46M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 4152.61M 3886.59M 3363.38M 2677.65M 1777.92M
Intangible assets 46.11M 14.57M 0.00M 0.00M 7.30M
Other current assets 141.03M 221.62M 149.20M 0.00M 179.43M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash -1.56M 3.72M 0.63M -0.53M -2.23M
Operating Cash 340.32M 244.67M 353.14M 356.99M 145.77M
Free Cash Flow -135.52M -350.93M -468.81M -618.33M -209.69M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
SAKAR
Sakar Healthcare Limited 		3.30 0.85% 391.10 8567.05 43.85
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-3.60 -0.21% 1700.80 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		85.50 1.41% 6140.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-43.20 -1.07% 3980.30 1362716.66 63.48
CIPLA
Cipla Limited 		5.60 0.42% 1332.30 1183505.97 21.74

Profile

Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analgesic, antihistamine, anthelmintic, anti-malarial, antibacterial, vitamins, antifungal, diuretics, oxytocic, antacid, laxative, anticoagulant, anaesthetic, bronchodilator, adrenergic, sedative, anti-inflammatory, antiemetic, anticonvulsant, antipsychotic, antidepressant, and anti-cancer. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.

Sakar Healthcare Limited

406, Silver Oaks Comm. Complex, Ahmedabad, India, 380007

Key Executives

Name Title Year Born
Mr. Sanjay Surendra Shah Chairman & MD 1959
Mr. Aarsh Sanjay Shah Joint MD & Exec. Director 1991
Ms. Ritaben Sanjay Shah Whole-Time Director 1964
Mr. Dharmesh R. Thaker Chief Financial Officer NA
Mr. Bharat S. Soni Company Sec. & Compliance Officer 1990
Mr. Aarsh Sanjay Shah MD & Executive Director 1991
Mr. Sunil Vasantrao Marathe Technical Director 1970
Mr. Sudhir Ghuleas Chief Operating Officer NA
Mr. Raviraj Kariaas Senior Vice President of Finance & Accounts NA
Mr. Bharat S. Soni Company Secretary & Compliance Officer 1990

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.